Hungarian compulsory license for remdesivir raises a stir with BIO, PhRMA and the US Chamber of Commerce
Whilst TRIPS Council deliberations in 2020 witnessed some lively deliberations on the nature of legislative amendments to Hungary’ special legal order (State of Danger) to enable the provision of a “compulsory licence regime for public health purposes”, Hungary’s recent decision… Continue Reading